Evidence map›Paper›PMID 36389426›Full record

ArticlePeerJ2022

Development of a prediction model to estimate the 5-year risk of cardiovascular events and all-cause mortality in haemodialysis patients: a retrospective study.

Aihong Zhang, Lemuge Qi, Yanping Zhang, Zhuo Ren, Chen Zhao, Qian Wang, Kaiming Ren, Jiuxu Bai, Ning Cao

Abstract read
In one paragraph

Article in PeerJ, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aihong ZhangDepartment of Blood Purification, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Lemuge QiDepartment of Blood Purification, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Yanping ZhangDepartment of Blood Purification, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Zhuo RenDepartment of Blood Purification, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Chen ZhaoDepartment of Blood Purification, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Qian WangDepartment of Blood Purification, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Kaiming RenDepartment of Blood Purification, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Jiuxu BaiDepartment of Blood Purification, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Ning CaoDepartment of Blood Purification, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiovascular disease (CVD) is a major cause of mortality in patients on haemodialysis. The development of a prediction model for CVD risk is necessary to help make clinical decisions for haemodialysis patients. This retrospective study aimed to develop a prediction model for the 5-year risk of CV events and all-cause mortality in haemodialysis patients in China. Methods: We retrospectively enrolled 398 haemodialysis patients who underwent dialysis at the dialysis facility of the General Hospital of Northern Theater Command in June 2016 and were followed up for 5 years. The composite outcome was defined as CV events and/or all-cause death. Multivariable logistic regression with backwards stepwise selection was used to develop our new prediction model. Results: Seven predictors were included in the final model: age, male sex, diabetes, history of CV events, no arteriovenous fistula at dialysis initiation, a monocyte/lymphocyte ratio greater than 0.43 and a serum uric acid level less than 436 mmol/L. Discrimination and calibration were satisfactory, with a C-statistic above 0.80. The predictors lay nearly on the 45-degree line for agreement with the outcome in the calibration plot. A simple clinical score was constructed to provide the probability of 5-year CV events or all-cause mortality. Bootstrapping validation showed that the new model also has similar discrimination and calibration. Compared with the Framingham risk score (FRS) and a similar model, our model showed better performance. Conclusion: This prognostic model can be used to predict the long-term risk of CV events and all-cause mortality in haemodialysis patients. An MLR greater than 0.43 is an important prognostic factor.

Indexed as

Cardiovascular DiseasesRenal DialysisHumansMaleRetrospective StudiesRisk FactorsUric AcidUric AcidAll-cause mortalityCardiovascular eventsHaemodialysisMonocyte/lymphocyte ratioPrediction modelSerum uric acid

Identifiers

PMID36389426
PMCPMC9653067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.